top of page

Improving Access to Pain Relief for People in Palliative Care in LMICs

Short Summary


  • Moderate-to-severe pain remains untreated for millions of people in low- and middle-income countries despite the availability of inexpensive, effective opioid medicines

  • Regulatory, training, and supply barriers restrict access to opioids for palliative care

  • A new charity could address this gap by supporting policy reform, clinician training, and supply-chain strengthening to enable safe, appropriate access to pain relief

The Problem


What’s the problem?

  • In most LMICs, patients with advanced cancer, HIV, or other life-limiting illnesses receive little to no pain relief for moderate-to-severe pain

  • Although opioids are inexpensive and medically essential, access remains limited

  • Less than 5% of global opioid need for serious health-related suffering is met in LMICs, compared with 98% in high-income countries


Why does it matter?

  • Severe, untreated pain is one of the strongest negative influences on subjective wellbeing

  • Persistent pain undermines daily functioning and often causes profound psychological distress

  • For some patients, suffering is so intense that continued life in pain is described as worse than death

  • Effective palliative care enables people with life-limiting illness to live and die with dignity


Neglectedness:

  • There is substantial unmet need for opioid access in LMICs, alongside limited organized effort 

  • Existing efforts tend to be fragmented, under-resourced, or focused on only one part of the problem (training or advocacy alone)

  • Few organizations address the full set of barriers, including regulation, prescriber training, and supply chains, meaning progress remains slow even when there is political will

  • We have not found evidence that current efforts are close to saturation in any country

The Solution


What’s the proposed solution?

  • Support coordinated reform across regulation, training, and supply chains, to improve access to opioids for palliative care

  • Focus on palliative care as the entry point, where need is greatest, risks of misuse are lower, and the case for access is most widely accepted

  • Work as a technical partner to the government, supporting policy reform and implementation rather than delivering services directly

  • Sequence activities: begin with policy reform to enable access, then support training and supply chains to ensure opioids are available, prescribed and used safely


Why do we trust this solution?

  • Evidence from prior initiatives suggest that isolated reforms are unlikely to succeed on their own

  • Case studies show that coordinated action across policy, training, and supply systems, can increase opioid access without replicating high-income-country harms

  • Progress appears to depend on combining legal reform with operational capacity and clinician confidence, rather than focusing on any single constraint alone


How robust is the evidence?

  • The evidence base is wide, but programmatic and qualitative

  • Patient-level outcome data are limited, with most programs tracking opioids dispensed rather than pain scores or quality-of-life outcomes

  • Given the policy-driven nature of the intervention, this type of evidence is broadly consistent with what we expected

The Impact


What impact could this have?

  • At scale, this intervention could avert a substantial burden of untreated pain in LMICs

  • Our modeling suggests an average impact of ~146,000 DALYs averted per year, with wide variation depending on country context


Estimated cost-effectiveness:

  • Advocacy for improved opioid access appears highly cost-effective in several settings

  • Across the ten countries modeled, estimated cost-effectiveness ranges from $145 to $1,096 per DALY averted, with an average of $151 per DALY averted

  • This meets our cost-effectiveness bar of $220/DALY averted in 8 out of the 10 countries analyzed

Ideal Founder Profile


  • Who is best suited to do this? *

    • Founders with an interest in policy advocacy and systems change, and who are comfortable working on problems with long timelines, limited short-term feedback, and high dependence on outside actors

  • What might our ideal candidate look like? 

    • Individuals who are able to build and maintain relationships with key stakeholders, and who are comfortable navigating bureaucratic and political environments 

    • Experience in monitoring, evaluation, and learning, public health, or government would be an advantage but not essential


*We think candidates with the following skills will have a comparative advantage/be especially promising for founding this idea, but we would like to still encourage applicants from people who do not match this criteria who are enthusiastic about this idea and believe they may be well-suited for reasons not captured here


Be a charity entrepreneur

We are actively seeking founders to bring these well-researched ideas to life.

 

If you are interested in founding a high-impact nonprofit, why learn more about we support aspiring and experience non-profit entrepreneurs through our Charity Entrepreneurship Incubation Program.

Have questions?

We want to answer them!

Ideas Q&A.png

Charity Entrepreneurship (CE) is a registered charity in England and Wales (Charity Number 1195850). CE supports its incubated charities through a fiscal sponsorship with Players Philanthropy Fund (Federal Tax ID: 27-6601178, ppf.org/pp), a Maryland charitable trust with federal tax-exempt status as a public charity under Section 501(c)(3) of the Internal Revenue Code.


Privacy Policy: ​You can read our Privacy Policy here
Terms of Use: You can read our Terms of Use here

Connect

  • LinkedIn
  • Facebook
  • Twitter
  • YouTube

Contact us

Please use our contact form.

bottom of page